NCT04798651View on ClinicalTrials.gov

Pathogenicity of B and CD4 T Cell Subsets in Multiple Sclerosis

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 30, 2021

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions
Multiple SclerosisClinically Isolated Syndrome
Interventions
BIOLOGICAL

blood sample

28 ml whole blood for Peripheral blood mononuclear cell (PBMC) and monocytes isolation

BIOLOGICAL

cerebro-spinal fluid

1 ml of cerebro-spinal fluid

Trial Locations (1)

Unknown

RECRUITING

CHU de Bordeaux - service de neurologie, Bordeaux

All Listed Sponsors
collaborator

University of Bordeaux

OTHER

lead

University Hospital, Bordeaux

OTHER